Skip to main content
logo
Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
153.81
-0.84 (-0.54%)
Aug 28, 2026, 4:00 PM EDT - Market closed

Novartis AG Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
14,95113,52413,86014,35814,83613,62013,55813,17212,87212,12011,77612,09211,74511,04710,96610,783-12,81413,52213,367
Revenue Growth
0.78%-0.70%2.23%9.00%15.26%12.38%15.13%8.93%9.60%9.71%7.39%12.14%--13.79%-18.90%-19.33%-0.95%3.78%6.61%
Gross Profit
11,27310,08610,31810,82311,51410,39310,2469,9389,6999,0249,2068,9758,4038,0568,2107,909-8,9589,9789,429
Operating Income
5,1764,1223,8554,5855,0114,7045,3063,6343,9853,3896,0611,6662,9132,0834,8691,925-2,8914,4093,175
Net Income
3,2643,1562,4093,9284,0413,6062,8183,1893,2462,6888,4801,7612,3162,2931,4661,573-2,22216,3082,758
Earnings Per Share
1.711.651.252.022.061.821.411.571.591.314.110.851.111.080.690.72-0.997.241.22
EPS Growth
-16.99%-9.34%-11.57%28.66%29.56%38.93%-65.63%84.60%43.00%21.53%498.67%17.73%-8.88%-90.53%-40.79%-8.79%686.13%45.24%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cardiovascular, Renal And Metabolic
1,6881,7731,6012,1852,6552,5182,4032,0632,0802,0301,7581,5751,5941,4631,3331,1691,1471,107953929
Immunology
2,7802,4662,7242,6112,5492,4092,4082,4832,3212,0812,0572,0331,9501,7581,7041,8681,9021,8131,9001,884
Neuroscience
1,8771,5611,6251,6091,4571,3021,2921,2251,2251,0089961,0348677548367527586921,2861,319
Oncology
4,5154,0214,2564,3753,3532,8833,8243,7223,5273,2243,3463,2843,2382,9843,0252,8692,7412,5402,7382,669
Established Brands
3,5483,2923,1303,1294,0404,1213,2263,3303,3593,4863,2663,8563,7883,8393,6783,5463,6513,7722,9702,961
Revenue (Total)
14,95113,52413,86014,35814,83613,62013,55813,17212,87212,12011,77612,09211,74511,04710,96610,78313,08512,81413,52213,367

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
7,6186,89211,5339,6686,7327,13713,35113,8518,4319,70314,07312,81611,07212,18718,72619,01019,63718,72128,2248,110
Total Debt
49,01446,99835,45732,02232,63731,27031,40132,15928,98727,28426,43925,18928,34029,20427,96428,53831,08731,34131,09334,329
Net Cash (Debt)
-41,396-40,106-23,924-22,354-25,905-24,133-18,050-18,308-20,556-17,581-12,366-12,373-17,268-17,017-9,238-9,528-11,450-12,620-2,869-26,219
Net Cash Growth
--------------------
Net Cash Per Share
-21.63-20.93-12.40-11.52-13.22-12.19-9.01-9.03-10.05-8.55-5.99-5.96-8.24-8.03-4.28-4.37--5.64-1.27-11.63

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
5,8823,6762,2646,5716,6643,6454,1936,2864,8752,2652,5475,3783,5762,9574,1114,721-1,6493,8844,925
Capital Expenditures
-321-346-609-354-331-254-558-321-260-227-406-261-225-168-306-221--257-460-351
Free Cash Flow
5,5613,3301,6556,2176,3333,3913,6355,9654,6152,0382,1415,1173,3512,7893,8054,500-1,3923,4244,574
Free Cash Flow Growth
-12.19%-1.80%-54.47%4.23%37.23%66.39%69.78%16.57%37.72%-26.93%-43.73%13.71%-100.36%11.13%-1.62%--26.11%-1.72%58.98%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
75.40%74.58%74.44%75.38%77.61%76.31%75.57%75.45%75.35%74.45%78.18%74.22%71.55%72.92%74.87%73.35%-69.91%73.79%70.54%
Operating Margin
34.62%30.48%27.81%31.93%33.78%34.54%39.14%27.59%30.96%27.96%51.47%13.78%24.80%18.86%44.40%17.85%-22.56%32.61%23.75%
Pretax Margin
28.55%28.39%23.22%29.22%30.54%32.36%24.23%25.70%29.84%25.82%20.19%12.83%22.77%22.81%14.31%14.72%-20.83%125.36%24.16%
Profit Margin
21.83%23.34%17.38%27.36%27.24%26.48%20.79%24.21%25.22%22.18%72.01%14.56%19.72%20.76%13.37%14.59%-17.34%120.60%20.63%
FCF Margin
37.20%24.62%11.94%43.30%42.69%24.90%26.81%45.28%35.85%16.81%18.18%42.32%28.53%25.25%34.70%41.73%-10.86%25.32%34.22%

Dividends
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Dividend Per Share
--4.666---3.862---3.919---3.461---3.401
Dividend Per Share Growth
--20.81%----1.44%---13.24%---1.77%----
Dividend Yield
--3.45%---4.14%---4.15%---4.43%---4.64%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
22.4821.2418.9716.8917.3516.3316.3913.2313.5013.9113.9527.0927.5839.2036.968.36-8.158.2018.78
P/FCF Ratio
17.1116.4015.0712.4212.2611.9312.0415.7815.7016.7715.4614.1014.6018.8420.0518.03-14.9414.3913.39
PS Ratio
5.065.084.684.314.293.953.784.664.474.444.444.634.746.375.634.53-3.723.733.52